1-Pyrrolidin-2-(N-Cbz-N-methyl)amino-ethane, 97.0%, 1g

ETHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 5g

4-Bromo-1-ethynyl-2-fluorobenzene, 95+%, 250mg

4-Amino-2-(trifluoromethyl)benzoic acid, 98.0%, 1g

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

N-(3,4,5-TRIFLUORO-2-NITROPHENYL)ACETAMIDE, 95.0%, 2g

(4-Isopropoxyphenyl)hydrazine hydrochloride, 95.0%, 250mg

5-(2-Ethoxyphenyl)-5-oxovaleric acid, 97.0%, 1g

Tin(II) chloride dihydrate, min. 98%, pa, ACS, 100 g, glass packaging

4-(3-Methylphenyl)benzoic acid, 95.0%, 5g

(R)-2-(3-CHLOROPHENYL)-2-HYDROXYACETIC ACID, 95.0%, 5g

5-Bromo-1H-inden-2(3H)-one, 95.0%, 5g

1-Phenoxy-4-vinylbenzene, 95.0%, 5g